Partner Content Partner Content Sanofi Joins the Speaker Line-up for SMi's Launch, Injectabl... Injectable Drug Delivery
Partner Content Partner Content Transforming complex biologics delivery and enhancing patien... Amgen unveil novel drug delivery technologies
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
